OPC Pharmaceutical JSC (HOSE:OPC)

OPC Pharmaceutical JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	185,519	175,594	294,274	86,591	199,564	59,437
Short-Term Investments	69,000	71,624	27,018	69,345	18,516	30,335
Trading Asset Securities	68.95	68.95	68.95	159,269	68.95	68.95
Cash & Short-Term Investments	254,588	247,287	321,361	315,205	218,148	89,841
Cash Growth	-15.90%	-23.05%	1.95%	44.49%	142.82%	-7.56%
Accounts Receivable	235,398	250,721	219,136	162,534	126,704	138,585
Other Receivables	-27,510	3,040	1,163	2,757	782.12	674.36
Receivables	207,888	253,762	220,299	165,291	127,486	139,260
Inventory	398,133	383,110	358,590	410,551	522,621	538,564
Prepaid Expenses	1,174	1,126	1,029	555.45	380.34	341.98
Other Current Assets	22,565	18,550	26,391	19,655	17,690	22,201
Total Current Assets	884,348	903,835	927,671	911,258	886,325	790,208
Property, Plant & Equipment	152,924	160,436	171,073	176,583	190,985	198,624
Long-Term Investments	25,444	24,996	24,385	24,203	23,688	25,208
Other Intangible Assets	73,636	73,945	73,928	75,031	76,131	77,231
Long-Term Deferred Tax Assets	2,831	4,559	9,523	3,155	3,305	1,770
Other Long-Term Assets	57,330	53,801	54,241	55,994	57,766	59,584
Total Assets	1,196,513	1,221,572	1,260,821	1,246,225	1,238,201	1,152,625
Accounts Payable	42,317	64,034	43,670	51,685	71,055	44,047
Accrued Expenses	39,636	50,417	82,895	92,016	93,386	86,311
Short-Term Debt	-	-	-	-	71,337	76,589
Current Income Taxes Payable	-	10,332	15,645	12,254	12,496	12,723
Current Unearned Revenue	4,293	-	3,262	28.45	186.75	2,364
Other Current Liabilities	213,484	215,185	226,274	212,853	241,172	215,123
Total Current Liabilities	299,730	339,969	371,747	368,836	489,633	437,157
Other Long-Term Liabilities	4,602	4,785	4,911	5,424	5,545	4,953
Total Liabilities	304,331	344,754	376,657	374,260	495,177	442,110
Common Stock	640,509	640,509	640,509	640,509	265,773	265,773
Additional Paid-In Capital	880.7	880.7	880.7	880.7	16,681	16,681
Retained Earnings	186,093	170,819	180,558	168,443	398,705	363,182
Total Common Equity	827,482	812,208	821,948	809,833	681,158	645,635
Minority Interest	64,700	64,610	62,216	62,131	61,865	64,879
Shareholders' Equity	892,182	876,818	884,164	871,964	743,023	710,515
Total Liabilities & Equity	1,196,513	1,221,572	1,260,821	1,246,225	1,238,201	1,152,625
Total Debt	-	-	-	-	71,337	76,589
Net Cash (Debt)	254,588	247,287	321,361	315,205	146,811	13,252
Net Cash Growth	-15.90%	-23.05%	1.95%	114.70%	1007.84%	-
Net Cash Per Share	-	3860.79	5017.28	4921.17	2292.11	206.90
Filing Date Shares Outstanding	-	64.05	64.05	64.05	64.05	64.05
Total Common Shares Outstanding	-	64.05	64.05	64.05	64.05	64.05
Working Capital	584,618	563,866	555,924	542,422	396,693	353,051
Book Value Per Share	-	12680.67	12832.73	12643.58	10634.58	10079.98
Tangible Book Value	753,846	738,264	748,020	734,802	605,027	568,404
Tangible Book Value Per Share	-	11526.20	11678.52	11472.15	9445.99	8874.21
Buildings	-	301,197	298,115	294,247	292,887	276,647
Machinery	-	259,564	259,681	251,688	249,240	237,597
Construction In Progress	21,829	24,288	21,639	17,079	14,351	28,318

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.